Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation

Respiratory Research

Volumn 8, Issue , 2007, Pages

  Gereke, Marcus ^a   Gröbe, Lothar ^a   Prettin, Silvia ^a   Kasper, Michael ^b   Deppenmeier, Stefanie ^c   Gruber, Achim D ^c   Enelow, Richard I ^d   Buer, Jan ^a,e   Bruder, Dunja ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; INFLAMMATION; LUNG; LUNG ALVEOLUS; METABOLISM; MOUSE; PATHOLOGY; RESPIRATORY TRACT MUCOSA; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION REGULATION; IMMUNOPHENOTYPING; INFLAMMATION; LUNG; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PULMONARY ALVEOLI; RESPIRATORY MUCOSA;

EID: 34848913477     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-8-47     Document Type: Article

References (43)

1. Folkerts G, Nijkamp FP. Airway epithelium: more than just a barrier!. Trends Pharmacol Sci 1998, 19:334-341. 10.1016/S0165-6147(98)01232-2, 9745362.
2. Knight DA, Holgate ST. The airway epithelium: structural and functional properties in health and disease. Respirology 2003, 8:432-446. 10.1046/j.1440-1843.2003.00493.x, 14708552.
3. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982, 126:332-337.
4. Kalina M, Mason RJ, Shannon JM. Surfactant protein C is expressed in alveolar type II cells but not in Clara cells of rat lung. Am J Respir Cell Mol Biol 1992, 6:594-600.
5. Lesur O, Arsalane K, Lane D. Lung alveolar epithelial cell migration in vitro: modulators and regulation processes. Am J Physiol 1996, 270:L311-L319.
6. Lubman RL, Danto SI, Crandall ED. Evidence for active H+ secretion by rat alveolar epithelial cells. Am J Physiol 1989, 257:L438-L445.
7. Lubman RL, Crandall ED. Regulation of intracellular pH in alveolar epithelial cells. Am J Physiol 1992, 262:L1-14.
8. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999, 13:1455-1476. 10.1183/09031936.99.13614779, 10445627.
9. Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2001, 2:33-46. 59567, 11686863, 10.1186/rr36.
10. Mason RJ, Williams MC. Type II alveolar cell. Defender of the alveolus. Am Rev Respir Dis 1977, 115:81-91.
11. Schneeberger EE, DeFerrari M, Skoskiewicz MJ, Russell PS, Colvin RB. Induction of MHC-determined antigens in the lung by interferon-gamma. Lab Invest 1986, 55:138-144.
12. Zissel G, Ernst M, Rabe K, Papadopoulos T, Magnussen H, Schlaak M, Muller-Quernheim J. Human alveolar epithelial cells type II are capable of regulating T-cell activity. J Investig Med 2000, 48:66-75.
13. Zhao MQ, Foley MP, Stoler MH, Enelow RI. Alveolar epithelial cell chemokine expression induced by specific antiviral CD8+ T-cell recognition plays a critical role in the perpetuation of experimental interstitial pneumonia. Chest 2001, 120:11S-13S. 10.1378/chest.120.1_suppl.S11, 11451886.
14. Zhao MQ, Amir MK, Rice WR, Enelow RI. Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation. Am J Respir Cell Mol Biol 2001, 25:362-369.
15. Bruder D, Westendorf AM, Geffers R, Gruber AD, Gereke M, Enelow RI, Buer J. CD4 T Lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions. Am J Respir Crit Care Med 2004, 170:1145-1152. 10.1164/rccm.200404-464OC, 15306530.
16. Kirberg J, Baron A, Jakob S, Rolink A, Karjalainen K, von BH. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med 1994, 180:25-34. 10.1084/jem.180.1.25, 8006585.
17. Corti M, Brody AR, Harrison JH. Isolation and primary culture of murine alveolar type II cells. Am J Respir Cell Mol Biol 1996, 14:309-315.
18. Weller NK, Karnovsky MJ. Identification of a 185 kd Maclura pomifera agglutinin binding glycoprotein as a candidate for a differentiation marker for alveolar type II cells in adult rat lung. Am J Pathol 1989, 134:277-285. 1879598, 2916648.
19. Website title. [NCBI: GSE5300]., http://www.ncbi.nlm.nih.gov/projects/geo
20. Baumer I, Zissel G, Schlaak M, Muller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997, 16:171-177.
21. Semenzato G, Bortoli M, Agostini C. Applied clinical immunology in sarcoidosis. Curr Opin Pulm Med 2002, 8:441-444. 10.1097/00063198-200209000-00017, 12172450.
22. Cosio MG, Majo J, Cosio MG. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002, 121:160S-165S. 10.1378/chest.121.5_suppl.160S, 12010846.
23. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003, 111:450-463. 10.1067/mai.2003.169, 12642820.
24. Duncan SR, Leonard C, Theodore J, Lega M, Girgis RE, Rosen GD, Theofilopoulos AN. Oligoclonal CD4(+) T cell expansions in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 2002, 165:1439-1444. 10.1164/rccm.2107009, 12016109.
25. Buckley S, Bui KC, Hussain M, Warburton D. Dynamics of TGF-beta 3 peptide activity during rat alveolar epithelial cell proliferative recovery from acute hyperoxia. Am J Physiol 1996, 271:L54-L60.
26. Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005, 42:799-809. 10.1016/j.molimm.2004.06.040, 15829268.
27. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, Hartson L, Sprague F, Goodrich S, Woodland DL, Lund FE, Randall TD. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004, 10:927-934. 10.1038/nm1091, 15311275.
28. Chvatchko Y, Kosco-Vilbois MH, Herren S, Lefort J, Bonnefoy JY. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J Exp Med 1996, 184:2353-2360. 10.1084/jem.184.6.2353, 8976189.
29. Tschernig T, Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 2000, 68:1-8. 10.1159/000028109, 10859525.
30. Bienenstock J, Johnston N. A morphologic study of rabbit bronchial lymphoid aggregates and lymphoepithelium. Lab Invest 1976, 35:343-348.
31. Plesch BE, Gamelkoorn GJ, van de EM. Development of bronchus associated lymphoid tissue (BALT) in the rat, with special reference to T- and B-cells. Dev Comp Immunol 1983, 7:179-188. 10.1016/0145-305X(83)90066-6, 6601592.
32. Matzer SP, Rodel F, Strieter RM, Rollinghoff M, Beuscher HU. Constitutive expression of CXCL2/MIP-2 is restricted to a Gr-1high, CD11b+, CD62Lhigh subset of bone marrow derived granulocytes. Int Immunol 2004, 16:1675-1683. 10.1093/intimm/dxh169, 15466452.
33. Cassatella MA, Gasperini S, Calzetti F, McDonald PP, Trinchieri G. Lipopolysaccharide-induced interleukin-8 gene expression in human granulocytes: transcriptional inhibition by interferon-gamma. Biochem J 1995, 310(Pt 3):751-755. 1135962, 7575406.
34. Galligan C, Yoshimura T. Phenotypic and functional changes of cytokine-activated neutrophils. Chem Immunol Allergy 2003, 83:24-44.
35. Maurer M, von SE. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004, 36:1882-1886. 10.1016/j.biocel.2003.10.019, 15203102.
36. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, Lebecque S, zutter-Dambuyant C, Schmitt D, Zlotnik A, Caux C. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000, 192:705-718. 10.1084/jem.192.5.705, 10974036.
37. Reibman J, Hsu Y, Chen LC, Bleck B, Gordon T. Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. Am J Respir Cell Mol Biol 2003, 28:648-654. 10.1165/rcmb.2002-0095OC, 12760962.
38. Matthews SP, Tregoning JS, Coyle AJ, Hussell T, Openshaw PJ. Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection. J Virol 2005, 79:2050-2057. 546549, 15681407, 10.1128/JVI.79.4.2050-2057.2005.
39. Ramana CV, Chintapalli J, Xu L, Alia C, Zhou J, Bruder D, Enelow RI. Lung epithelial NF-kappaB and Stat1 signaling in response to CD8+ T cell antigen recognition. J Interferon Cytokine Res 2006, 26:318-327. 10.1089/jir.2006.26.318, 16689660.
40. Bui KC, Wu F, Buckley S, Wu L, Williams R, Carbonaro-Hall D, Hall FL, Warburton D. Cyclin A expression in normal and transformed alveolar epithelial cells. Am J Respir Cell Mol Biol 1993, 9:115-125.
41. Wu F, Buckley S, Bui KC, Warburton D. Differential expression of cyclin D2 and cdc2 genes in proliferating and nonproliferating alveolar epithelial cells. Am J Respir Cell Mol Biol 1995, 12:95-103.
42. Chakrabarti S, Patel KD. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res 2005, 31:599-621. 10.1080/019021490944232, 16019990.
43. Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 1996, 149:1241-1256. 1865188, 8863673.